Dr Reddy’s, Hyderabad’s well-known pharma firm has announced on Monday that they have come up with an anti-COVID drug called 2-DG or 2-deoxy-D-glucose. They have, in fact, announced the commercial launch and said that the drug manufacturing company will now supply the drug to major government as well as private hospitals across India.
During the initial days, however, the company will make the drug available in metros and tier-1 cities while they will eventually extend the coverage to the rest of India. 2-DG has a purity of 99.5% and will be sold commercially as 2DG. The retail price of the sachet has been fixed at Rs 990, though a subsidized price will be offered to government institutions.
2-DG was developed in collaboration with Nuclear Medicine and Allied Sciences (INMAS), a lab that is part of DRDO or the Defence Research and Development Organisation. The Drug Controller General of India (GCGI) approved its emergency use on May 1. Defence minister Rajnath Singh and union health minister Dr Harsha Vardhan released the first batch of the drug on May 17.